Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Artificial Intelligence and Healthcare
    • Consumer-Driven Health Care
      • Affordable Care Act
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Health Economics & Costs
      • Drug Prices & Regulations
      • Health Insurance
      • Health Reform
    • Medical Tourism
    • Telemedicine
    • Medicare
      • Single-Payer/Medicare-for-All
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Author: John C. Goodman

Tuesday Links

Posted on March 7, 2023March 7, 2023 by John C. Goodman
  • Does lead in the air affect learning in school?
  • Stephen Pinker: The development of artificial general intelligence is incoherent and not achievable.
  • Increased access to physicians results in better health – at least in Nigeria.
  • If the estimates from Statista Consumer Marketing Research are accurate, from 2020 to 2022 the world bought 928 billion masks at a cost of $389 billion — most of them made of plastic. I wonder how much of the plastic ended up in the ocean?
  • Oops. The Inflation Reduction Act will increase taxes on millions of Americans earning less than $400,000, despite the president’s repeated promises not to do that. And that’s only for starters.
+

Monday Links

Posted on March 6, 2023March 6, 2023 by John C. Goodman
  • The IRA bill threatens orphan drugs.
  • Study finds links between the popular zero-calorie sugar substitute erythritol and an increased risk of cardiovascular events, including heart attack and stroke.
  • But the study has limits. (NYT)
  • Death on demand: Canadian euthanasia is killing about 27 people a day on average — over 10,000 a year.
+

“Escape >From the Lab” is Not Just Theory

Posted on March 6, 2023 by John C. Goodman

“What this means, in non-technical language, is that Shi set out to create novel coronaviruses with the highest possible infectivity for human cells. Her plan was to take genes that coded for spike proteins possessing a variety of measured affinities for human cells, ranging from high to low. She would insert these spike genes one by one into the backbone of a number of viral genomes (“reverse genetics” and “infectious clone technology”), creating a series of chimeric viruses. These chimeric viruses would then be tested for their ability to attack human cell cultures (“in vitro”) and humanized mice (“in vivo”). And this information would help predict the likelihood of “spillover,” the jump of a coronavirus from bats to people.

“The methodical approach was designed to find the best combination of coronavirus backbone and spike protein for infecting human cells. The approach could have generated SARS2-like viruses, and indeed may have created the SARS2 virus itself with the right combination of virus backbone and spike protein.

“It cannot yet be stated that Shi did or did not generate SARS2 in her lab because her records have been sealed, but it seems she was certainly on the right track to have done so. “It is clear that the Wuhan Institute of Virology was systematically constructing novel chimeric coronaviruses and was assessing their ability to infect human cells and human-ACE2-expressing mice,” says Richard H. Ebright, a molecular biologist at Rutgers University and leading expert on biosafety.

+

How to Create Transparent Pricing

Posted on March 3, 2023March 3, 2023 by John C. Goodman

James Capretta and David Bernstein (AEI) recommend these changes for CMS:

  1. Require transparent, “all in” prices for standardized services required to fully complete a clinical intervention.
  2. Require all providers to participate in this bundled pricing system.
  3. The prices posted for these services should be “walk up” prices available to all patients, irrespective of their insurance status.
  4. Require insurers to make available to their enrollees the dollar value of their median out-of-network rates, so that patients could then apply those payments from their insurers to any provider of their choosing.
  5. An additional option would be to allow patients to place the dollars saved by selecting lower-priced providers into tax-free health savings accounts (HSAs) for future use.
  6. +
  • Previous
  • 1
  • …
  • 207
  • 208
  • 209
  • 210
  • 211
  • 212
  • 213
  • …
  • 279
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 36 other subscribers

Popular Topics

©2025 The Goodman Institute Health Blog | Website by Lexicom